These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16796699)

  • 1. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction.
    Berger AP; Deibl M; Leonhartsberger N; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer AE; Bartsch G; Frauscher F
    BJU Int; 2005 Nov; 96(7):1073-8. PubMed ID: 16225531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
    Marks LS; Roehrborn CG; Wolford E; Wilson TH
    J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic characterization of hereditary benign prostatic hyperplasia.
    Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
    Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
    Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
    Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
    Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
    Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia.
    Abdelwahab O; El-Barky E; Khalil MM; Kamar A
    Int Braz J Urol; 2012; 38(2):250-5; discussion 255-7. PubMed ID: 22555031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.
    Berger AP; Deibl M; Halpern EJ; Lechleitner M; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer A; Bartsch G; Frauscher F
    Diabetologia; 2005 Apr; 48(4):784-9. PubMed ID: 15756540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power and pulsed Doppler evaluation of prostatic artery blood flow in normal and benign prostatic hyperplasia-affected dogs.
    Zelli R; Orlandi R; Troisi A; Cardinali L; Polisca A
    Reprod Domest Anim; 2013 Oct; 48(5):768-73. PubMed ID: 23505997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis as a risk factor for benign prostatic hyperplasia.
    Berger AP; Bartsch G; Deibl M; Alber H; Pachinger O; Fritsche G; Rantner B; Fraedrich G; Pallwein L; Aigner F; Horninger W; Frauscher F
    BJU Int; 2006 Nov; 98(5):1038-42. PubMed ID: 16879445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.
    Pinggera GM; Frauscher F; Paduch DA; Bolyakov A; Efros M; Kaminetsky J; Da Pozzo L; Esler A; Cox D
    Urology; 2014 Aug; 84(2):412-9. PubMed ID: 24938580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
    Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
    Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arteriosclerosis related factors had no clinical significant correlation with resistive index in symptomatic benign prostatic hyperplasia.
    Takada S; Kurita Y; Imanishi T; Otsuka A; Shinbo H; Furuse H; Nakanishi T; Suzuki A; Takase H; Ozono S
    Urology; 2011 Feb; 77(2):433-7. PubMed ID: 21168193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring resistance index in patients with BPH and lower urinary tract symptoms.
    Ozdemir H; Onur R; Bozgeyik Z; Orhan I; Ogras MS; Ogur E
    J Clin Ultrasound; 2005 May; 33(4):176-80. PubMed ID: 15856514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign prostatic hyperplasia: age-related tissue-remodeling.
    Untergasser G; Madersbacher S; Berger P
    Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics.
    Laczkó I; Hudson DL; Freeman A; Feneley MR; Masters JR
    Prostate; 2005 Feb; 62(3):260-6. PubMed ID: 15389778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.